2013
|
Invention
|
Pharmaceutical compositions comprising a pancreatic enzyme preparation with viral infectivity red... |
|
Invention
|
Gastro-resistant enzyme pharmaceutical compositions.
The present invention generally relates to ... |
|
Invention
|
Methods for purifying monosaccharide mixtures containing ionic impurities.
Disclosed herein are ... |
2011
|
Invention
|
Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid.
The... |
|
Invention
|
Gastro-resistant enzyme pharmaceutical compositions. The present invention generally relates to c... |
|
Invention
|
Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations. ... |
2010
|
Invention
|
Mesalamine suppository. The present invention relates to a mesalamine rectal suppository designed... |
|
Invention
|
Methods for purifying monosaccharide mixtures containing ionic impurities. Disclosed herein are m... |
|
G/S
|
Pharmaceutical preparations in the form of liquid, powder, tablets, capsules or granules, for the... |
|
Invention
|
Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid. The ... |
2007
|
Invention
|
Process for preparation of aldonic acids and derivatives thereof.
A process for the preparation ... |
1998
|
Invention
|
A double capsule for the administration of active principles in multiple therapies. A pharmaceuti... |
1996
|
Invention
|
Stable aqueous suspensions of mesalazine. The invention discloses new compositions of mesalazine ... |
1995
|
G/S
|
Imprimés, nommément: bulletins d'information, rapports d'études, textes de conférences servant à ... |
|
G/S
|
Pharmaceutical preparations for treatment of gastric conditions. |
1990
|
G/S
|
Produits pharmaceutiques, nommément: acide aminosalicylique, mésalazine, fisalamine sous formes p... |
1982
|
G/S
|
Pharmaceutical preparation, namely, ulcer medication. |
1958
|
G/S
|
ANTISPASMODIC IN CAPSULE, TABLET, SYRUP, AND INJECTABLE FORMS AND AS AN INGREDIENT IN OTHER PREPA... |